Dmitry Y. Tyrsin
Algemeen Directeur bij TheraMAB LLC
Profiel
Dmitry Y.
Tyrsin is currently the Chief Executive Officer at TheraMAB LLC.
Previously, he worked as a Senior Manager-Business Development at ChemDiv, Inc. from 2004 to 2008.
Dr. Tyrsin has a graduate degree from Moscow State University Lomonosov and a doctorate degree from Julius-Maximilians-Universität Würzburg.
Actieve functies van Dmitry Y. Tyrsin
| Bedrijven | Functie | Begin |
|---|---|---|
TheraMAB LLC
 TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Algemeen Directeur | - |
Eerdere bekende functies van Dmitry Y. Tyrsin
| Bedrijven | Functie | Einde |
|---|---|---|
ChemDiv, Inc.
 ChemDiv, Inc. Miscellaneous Commercial ServicesCommercial Services ChemDiv, Inc. operates as a discovery and development contract research organization. It specializes in early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. The firm?s services include synthetic chemistry, structural biology and structure-based drug discovery, molecular modeling, medicinal chemistry, scale-up, biochemical and cellular assay development, analytical/bioanalytical platforms, ADME/tox, DMPK, and multiple in vivo efficacy/tox models. The company was founded by Alexander Ivachtchenko in 1991 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-01-2008 |
Opleiding van Dmitry Y. Tyrsin
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
| Moscow State University Lomonosov | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
TheraMAB LLC
TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Health Technology |
ChemDiv, Inc.
ChemDiv, Inc. Miscellaneous Commercial ServicesCommercial Services ChemDiv, Inc. operates as a discovery and development contract research organization. It specializes in early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. The firm?s services include synthetic chemistry, structural biology and structure-based drug discovery, molecular modeling, medicinal chemistry, scale-up, biochemical and cellular assay development, analytical/bioanalytical platforms, ADME/tox, DMPK, and multiple in vivo efficacy/tox models. The company was founded by Alexander Ivachtchenko in 1991 and is headquartered in San Diego, CA. | Commercial Services |
